SPK PHARMA LTDActive

Company number 11211157Private limited companyIncorporated 2018

Key figures

£1,322,212+40.9%
Net assets 2024/25
+55.8%
Average annual growth 2020/21–2024/25
0500 k1 m1.5 m2020/212021/222022/232023/242024/25

Like most small UK companies, SPK PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand—389,076301,417314,168700,043
Total assets331,452521,273529,845653,6871,065,910
Total liabilities107,929109,795347,433172,823196,659
Net assets / total equity224,303422,302645,836938,5651,322,212
Average number of employees01222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: SPK PHARMA LTD

Company

SPK PHARMA LTD is a private limited company registered with Companies House under company number 11211157. It was incorporated on 19 Feb 2018. Its status is active. The registered office is in Leicester (LE4). Its nature of business (SIC 2007) is retail sale via mail order houses or via Internet (47910), other professional, scientific and technical activities n.e.c. (74909).

Accounts

The latest accounts in the database are for 2024/25 (period ending 28 Feb 2025); the company files abridged accounts (unaudited). Net assets were £1,322,212, up 40.9% on the previous year. Cash at bank and in hand was £700,043. Total assets were £1,065,910 and total liabilities £196,659. The company had an average of 2 employees. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 16 Feb 2027.